G - Physics
01
N
G01N 33/566 (2006.01) C07K 14/47 (2006.01) C07K 14/665 (2006.01) C07K 14/70 (2006.01) C07K 14/705 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2423596
The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays are based upon the binding of BAM-22P to the rat and human DRR receptors.
La présente invention concerne des dosages biologiques pouvant être utilisés pour sélectionner des composés qui agissent comme agonistes, antagonistes ou agonistes inverses du docosapeptide (BAM-22P) médullosurrénal bovin. Les dosages biologiques sont basés sur la liaison de la BAM-22P au rat et aux récepteurs DRR humains.
Ahmad Sultan
Grazzini Eric
Groblewski Thierry
Lembo Paola
Schmidt Ralf
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Assays does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assays will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1934199